964 results on '"Guillot, Bernard"'
Search Results
2. Délais administratifs des RTU, effet sur l’accès à l’innovation dans le mélanome
3. Basket clinical trial design for targeted therapies for cancer: a French National Authority for Health statement for health technology assessment
4. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial
5. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial
6. Patients with Metastatic Melanoma Receiving Anticancer Drugs: Changes in Overall Survival, 2010–2017
7. A Multicenter Phase II Study of Pazopanib in Patients with Unresectable Dermatofibrosarcoma Protuberans
8. Melanoma-associated retinopathy during pembrolizumab treatment probably controlled by intravitreal injections of dexamethasone
9. Management of scabies in children under 15 kg and pregnant or breastfeeding women: recommendations supported by the Centre of Evidence of the French Society of Dermatology.
10. Tumor infiltrating lymphocytes as adjuvant treatment in stage III melanoma patients with only one invaded lymph node after complete resection: results from a multicentre, randomized clinical phase III trial
11. Impact of radiotherapy administered simultaneously with systemic treatment in patients with melanoma brain metastases within MelBase, a French multicentric prospective cohort
12. MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial
13. STAT3 Mediates Nilotinib Response in KIT-Altered Melanoma: A Phase II Multicenter Trial of the French Skin Cancer Network
14. A comparative study of classic and HIV-viremic and aviremic AIDS Kaposi sarcoma
15. Hemophagocytic lymphohistiocytosis in advanced melanoma treated with dabrafenib and trametinib combination: two cases
16. DCG 3 - Le Droit social en fiches et en schémas
17. DCG 1 - Les fondamentaux du droit en fiches et en schémas
18. Actualisation des recommandations de prise en charge du mélanome stade I à III
19. Myasthenia Gravis Induced by Immune Checkpoint Inhibitors
20. Incidence and Clinical Impact of Anti-TNFα Treatment of Severe Immune Checkpoint Inhibitor-induced Colitis in Advanced Melanoma: The Mecolit Survey
21. Le site de référence du Partenariat européen d’innovation pour un vieillissement actif et en bonne santé MACVIA-LR (contre les maladies chroniques pour un vieillissement en bonne santé en Languedoc-Roussillon)
22. Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial
23. Cost-Effectiveness Analysis of Sequential Treatment Strategies for Advanced Melanoma in Real Life in France
24. Post-approval Studies in France, Challenges Facing Medical Devices
25. Les études post-inscriptions en France, quels enjeux pour les dispositifs médicaux
26. Guidelines for cold urticaria management established by the Centre of Evidence of Dermatology and the Urticaria Group of the French Society of Dermatology.
27. Nevus anemicus in neurofibromatosis type 1: A potential new diagnostic criterion
28. Treatments for classic Kaposi sarcoma: A systematic review of the literature
29. Adjuvant therapy with pegylated interferon alfa-2b (36 months) versus low-dose interferon alfa-2b (18 months) in melanoma patients without macrometastatic nodes: An open-label, randomised, phase 3 European Association for Dermato-Oncology (EADO) study
30. A family with two cases of melanocytic tumors and fragile X syndrome
31. Contraintes et spécificités de l’évaluation clinique des dispositifs médicaux
32. Clinical Evaluation of Medical Devices: Main Constraints and Specificities
33. Primary leptomeningeal melanocytic tumour with a plaque-like blue nevus in a patient with ocular albinism
34. Acute respiratory distress syndrome complicating generalized pustular psoriasis (psoriasis-associated aseptic pneumonitis)
35. Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium in asymptomatic patients under 30 years of age screened in a French sexually transmitted infections clinic
36. Inter-observer agreement between dermatologists and oncologists in assessing dermatological toxicities in patients with metastatic colorectal cancer treated by cetuximab-based chemotherapies: A pilot comparative study
37. Délais administratifs des RTU, effet sur l’accès à l’innovation dans le mélanome
38. Algorithme de prise en charge des teignes de l’enfant après l’arrêt de la commercialisation de la griséofulvine en France
39. Tacrolimus 0,1 % dans le vitiligo : pour une mise en conformité entre données de la science et prescription réglementaire
40. Les terroirs orientés du Congo-Brazzaville: essai d'interprétation
41. A comparative study of classic and HIV-viremic and aviremic AIDS Kaposi sarcoma
42. Drug-Induced Acneiform Eruption
43. Tatouages temporaires au henné : des effets indésirables parfois graves
44. Telaprevir-Induced Acquired Perforating Dermatosis
45. Highly sensitive detection of melanoma based on serum proteomic profiling
46. Complex t(5;8) involving the CSPG2 and PTK2B genes in a case of dermatofibrosarcoma protuberans without the COL1A1-PDGFB fusion
47. Tolerance and Effectiveness of Targeted Therapies in Aged Patients with Metastatic Melanoma
48. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial
49. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial
50. Identification and characterization of novel TRPM1 autoantibodies from serum of patients with melanoma-associated retinopathy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.